LONDON: AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen.

File – Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken on October 31, 2020. Photo: Reuters

“This vaccine‘s efficacy and safety confirm that it will be highly effective against COVID19 and will have an immediate impact on this public health emergency,” Pascal Soriot, Astra’s chief executive, said in a statement.

The British drugmaker’s preliminary trial results mark a fresh breakthrough in the fight against a pandemic that has killed nearly 1.4 million people and roiled the global economy.


Follow The Himalayan Times on
Twitter
and
Facebook

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here